4 August, 2021 by The TZ Newswire Staff Comments Off on Cathie Wood’s ARK Invest Sells Nearly 200,000 Shares of Snap
Cathie Wood’s ARK Invest Sells Nearly 200,000 Shares of Snap
One of Cathie Wood’s ARK Invest funds sold nearly 200,000 shares of Snap on August 3.
4 August, 2021 by The TZ Newswire Staff Comments Off on UK’s CapitalRise Announces Advancement of £9.2M Senior Loan for Refinancing of Georgian Townhouses in London
UK’s CapitalRise Announces Advancement of £9.2M Senior Loan for Refinancing of Georgian Townhouses in London
Dedicated Prime property lender CapitalRise announced the advancement of a £9.2 million senior loan for the refinancing and development of two freehold Georgian townhouses based in Bloomsbury, London “with a GDV of £14 million.” As mentioned in a release shared with CI, the loan will… Read More
4 August, 2021 by The TZ Newswire Staff Comments Off on What’s Behind Bitcoin’s Recent Rally?
What’s Behind Bitcoin’s Recent Rally?
The cryptocurrency mania that gripped investors for much of 2020 took a 180-degree turn in April. Since then, Bitcoin‘s (CRYPTO: BTC) value plunged by about 53% before rebounding 28% in the last two weeks.
The coin is now teetering near $38,000 levels after its short-term risk factors have dissipated somewhat. So can investors count on the iconic cryptocurrency once more to carry their account balance to the moon?
4 August, 2021 by The TZ Newswire Staff Comments Off on ADP Employment Report Shows Job Gains Stalled In June, Weakest Since Feb
ADP Employment Report Shows Job Gains Stalled In June, Weakest Since Feb
ADP Employment Report Shows Job Gains Stalled In June, Weakest Since Feb
Analysts expected a 7th straight month of ‘solid’ employment gains in July, forecasting ADP to show the US economy added 683k jobs (despite recent weakness in ISM Employment data). They were wrong, very wrong!
ADP printed a miserly addition of just 330k jobs in June (less than half the expected rise)… and well below the consensus forecast for Friday’s payrolls print.
4 August, 2021 by The TZ Newswire Staff Comments Off on How This Historic FDA Approval Benefits Viatris
How This Historic FDA Approval Benefits Viatris
U.S. biopharmaceutical company Viatris (NASDAQ: VTRS) and its partner, Indian biopharma Biocon, announced on July 28 that the U.S. Food and Drug Administration (FDA) had approved their biosimilar insulin drug, Semglee, as an “interchangeable biosimilar” — a direct alternative to Sanofi‘s (NASDAQ: SNY) blockbuster insulin drug, Lantus.
4 August, 2021 by The TZ Newswire Staff Comments Off on Energy Transfer’s Diversification Paid Dividends in Q2
Energy Transfer’s Diversification Paid Dividends in Q2
Energy Transfer‘s (NYSE: ET) second-quarter results weren’t the blowout it reported in the first quarter when it benefited from winter storms in Texas.
4 August, 2021 by The TZ Newswire Staff Comments Off on Open Banking: UK Fintech Modulr Says that Financial APIs are Driving the Financial Revolution
Open Banking: UK Fintech Modulr Says that Financial APIs are Driving the Financial Revolution
A completely digital economy has “always been on the horizon” and now, thanks to the Covid-19 outbreak, that horizon has been “brought to the forefront” of business operations, the team at UK-based Fintech Modulr writes in a blog post. Before the Coronavirus crisis, cashless payments… Read More